Drug Trial Radar · NCT03339297
An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)
Last checked: Nov 20, 2026Latest source record: Aug 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
152
Actual
Start
Feb 21, 2018
Primary completion
May 12, 2020
Study completion May 12, 2020
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Nov 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study comparing the defibrotide prophylaxis arm vs standard of care arm for the prevention of aGvHD.
Conditions
- Graft-versus-host Disease
- Acute-graft-versus-host Disease
Interventions
DefibrotideDrug
6.25 mg/kg via 2-hour IV infusion every 6 hours
Standard of CareDrug
Administered according to local institutional guidelines, physician preference, and patient need.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative Incidence Percentage of Grade B to D Acute Graft Versus Host Disease (aGvHD) by Day +100 Post-Hematopoietic Stem Cell Transplant (HSCT)Time frame: HSCT Day (Day +0 post-HSCT) through Day +100 post-HSCT
Locations
62 sites in 14 countries. Site status is shown where the registry gives one.
USC Norris Cancer Center
Los Angeles, California
Mattel Children's Hospital UCLA
Los Angeles, California
Stanford University
Palo Alto, California
University of California, San Francisco Medical Center
San Francisco, California
Mayo Clinic Jacksonville - PPDS
Jacksonville, Florida
Blood & Marrow Transplant Center
Orlando, Florida
Emory University Hospital
Atlanta, Georgia
Northwestern Memorial Hospital
Chicago, Illinois
University of Kansas Medical Center
Westwood, Kansas
James Graham Brown Cancer Center
Louisville, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
University of Nebraska Medical Center
Omaha, Nebraska
Montefiore Einstein Cancer Center
The Bronx, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania
MUSC-Hollings Cancer Center
Charleston, South Carolina
VA Puget Sound Health Care System
Seattle, Washington
West Virginia University Hospital
Morgantown, West Virginia
Universitätsklinikum Innsbruck
Innsbruck, Austria
Ordensklinikum Linz, Krankenhaus der Elisabethinen GmbH
Linz, Austria
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
Specialized Hospital for Active Treatment of Haematological Diseases - Sofia
Sofia, Bulgaria
Hôpital Maisonneuve-Rosemont
Montreal, Canada
Sainte Justine Hospital
Montreal, Canada
McGill University Health Center
Montreal, Canada
Klinichki Bolnicki Centar Zagreb
Zagreb, Croatia
Hospital d Instructions des Armees Percy
Clamart, France
CHRU Lille
Lille, France
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Institut Gustave Roussy
Villejuif, France
Helios Klinikum Berlin Buch
Berlin, Germany
Medizinische Universitätsklinik Knappschaftskrankenhaus
Bochum, Germany
Klinikum Frankfurt (Oder) GmbH
Brandenburg, Germany
Uniklinik Köln
Cologne, Germany
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Dresden, Germany
University Medicine Göttingen Germany
Göttingen, Germany
Universitaetsklinikum Halle (Saale)
Halle, Germany
Universitatsklinikum Leipzig
Leipzig, Germany
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.